» Articles » PMID: 29936554

Treatment of Visual Disorders in Parkinson Disease

Overview
Specialty Neurology
Date 2018 Jun 25
PMID 29936554
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: This article discusses visual disorders in both Parkinson disease (PD) and other Parkinsonian disorders. It is organized largely by the anatomical site of pathology and emphasizes practical treatments. Targeted treatment options include medications, surgery, occupational, and physical therapies as well as optical aids.

Recent Findings: The causes of visual complaints in Parkinson disease and other similar disorders are being more clearly identified. A new medication approved specifically to treat hallucinations in PD now is available. There is increased understanding of the important role that an ophthalmologist can play in the care of these patients. Finally, research and therapeutic development are unmet needs in accessing and treating visual complaints in PD and Parkinsonian disorders. A better understanding of Parkinson-related visual complaints and of available treatment options is important to optimize patient safety and quality of life. Vision impairment leads to difficulties in many common activities including reading, ambulating, and driving. Falls and injuries, made more likely because of impaired vision, result in an early loss of independence. Awareness of the problem, patient education, ophthalmologic care, selected therapeutics, physical therapy, and occupational therapy are crucial to maximizing quality of life in these patients.

Citing Articles

The feasibility of a visuo-cognitive training intervention using a mobile application and exercise with stroboscopic glasses in Parkinson's: Findings from a pilot randomised controlled trial.

Das J, Barry G, Walker R, Vitorio R, Celik Y, McDonald C PLOS Digit Health. 2024; 3(12):e0000696.

PMID: 39693278 PMC: 11654989. DOI: 10.1371/journal.pdig.0000696.


Reading Difficulties in Parkinson's Disease: A Stepped Care Model for Neurovisual Rehabilitation.

van der Lijn I, de Haan G, van der Feen F, Vrijling A, Stellingwerf C, Fuermaier A J Parkinsons Dis. 2023; 13(7):1225-1237.

PMID: 37781818 PMC: 10657659. DOI: 10.3233/JPD-230124.


The integration of technology into a home-based visuo-cognitive training intervention for people with Parkinson's: Is the future digital?.

Das J, Barry G, Walker R, Vitorio R, Morris R, Stuart S PLoS One. 2023; 18(6):e0285100.

PMID: 37319251 PMC: 10270359. DOI: 10.1371/journal.pone.0285100.


Prevalence and nature of self-reported visual complaints in people with Parkinson's disease-Outcome of the Screening Visual Complaints questionnaire.

van der Lijn I, de Haan G, van der Feen F, Huizinga F, Stellingwerf C, van Laar T PLoS One. 2023; 18(4):e0283122.

PMID: 37014842 PMC: 10072373. DOI: 10.1371/journal.pone.0283122.


Exploring the feasibility of technological visuo-cognitive training in Parkinson's: Study protocol for a pilot randomised controlled trial.

Das J, Morris R, Barry G, Vitorio R, Oman P, McDonald C PLoS One. 2022; 17(10):e0275738.

PMID: 36206239 PMC: 9543984. DOI: 10.1371/journal.pone.0275738.


References
1.
Archibald N, Clarke M, Mosimann U, Burn D . Visual symptoms in Parkinson's disease and Parkinson's disease dementia. Mov Disord. 2011; 26(13):2387-95. DOI: 10.1002/mds.23891. View

2.
Almer Z, Klein K, Marsh L, Gerstenhaber M, Repka M . Ocular motor and sensory function in Parkinson's disease. Ophthalmology. 2011; 119(1):178-82. PMC: 3251710. DOI: 10.1016/j.ophtha.2011.06.040. View

3.
Alvarez F . Parkinson's disease, antiparkinson medicines, and driving. Expert Rev Neurother. 2016; 16(9):1023-32. DOI: 10.1080/14737175.2016.1218278. View

4.
Gazulla J, Benavente M . [Improvements in the symptoms of olivopontocerebellar atrophy with gabapentin]. Rev Neurol. 2005; 40(5):285-8. View

5.
Domenici L, Trimarchi C, Piccolino M, Fiorentini A, Maffei L . Dopaminergic drugs improve human visual contrast sensitivity. Hum Neurobiol. 1985; 4(3):195-7. View